Larson Financial Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $578K | Buy |
6,338
+571
| +10% | +$52.1K | 0.02% | 396 |
|
|
2025
Q1 | $653K | Buy |
5,767
+1,998
| +53% | +$226K | 0.03% | 333 |
|
|
2024
Q4 | $398K | Buy |
3,769
+362
| +11% | +$38.2K | 0.02% | 405 |
|
|
2024
Q3 | $368K | Buy |
3,407
+1,302
| +62% | +$141K | 0.02% | 410 |
|
|
2024
Q2 | $228K | Buy |
2,105
+1,171
| +125% | +$127K | 0.02% | 422 |
|
|
2024
Q1 | $123K | Buy |
934
+591
| +172% | +$78K | 0.01% | 502 |
|
|
2023
Q4 | $41.7K | Buy |
343
+1
| +0.3% | +$122 | ﹤0.01% | 689 |
|
|
2023
Q3 | $38.4K | Hold |
342
| – | – | ﹤0.01% | 684 |
|
|
2023
Q2 | $49.8K | Sell |
342
-177
| -34% | -$25.8K | 0.01% | 561 |
|
|
2023
Q1 | $67.1K | Sell |
519
-316
| -38% | -$40.8K | 0.01% | 492 |
|
|
2022
Q4 | $106K | Buy |
835
+258
| +45% | +$32.9K | 0.01% | 395 |
|
|
2022
Q3 | $60K | Buy |
577
+217
| +60% | +$22.6K | 0.01% | 436 |
|
|
2022
Q2 | $38K | Buy |
360
+10
| +3% | +$1.06K | 0.01% | 426 |
|
|
2022
Q1 | $45K | Sell |
350
-11
| -3% | -$1.41K | 0.01% | 399 |
|
|
2021
Q4 | $44K | Buy |
361
+83
| +30% | +$10.1K | 0.01% | 403 |
|
|
2021
Q3 | $40K | Hold |
278
| – | – | 0.01% | 339 |
|
|
2021
Q2 | $43K | Hold |
278
| – | – | 0.01% | 304 |
|
|
2021
Q1 | $43K | Hold |
278
| – | – | 0.01% | 284 |
|
|
2020
Q4 | $42K | Hold |
278
| – | – | 0.01% | 242 |
|
|
2020
Q3 | $37K | Hold |
278
| – | – | 0.02% | 241 |
|
|
2020
Q2 | $32K | Buy |
278
+135
| +94% | +$15.5K | 0.02% | 236 |
|
|
2020
Q1 | $14K | Hold |
143
| – | – | 0.01% | 256 |
|
|
2019
Q4 | $21K | Hold |
143
| – | – | 0.01% | 221 |
|
|
2019
Q3 | $19K | Buy |
143
+100
| +233% | +$13.3K | 0.01% | 228 |
|
|
2019
Q2 | $5K | Hold |
43
| – | – | ﹤0.01% | 325 |
|
|
2019
Q1 | $5K | Hold |
43
| – | – | ﹤0.01% | 305 |
|
|
2018
Q4 | $4K | Buy |
+43
| New | +$4K | ﹤0.01% | 309 |
|